Short Interest in Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Increases By 22.9%

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF - Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,073,400 shares, a growth of 22.9% from the March 31st total of 873,500 shares. Approximately 0.5% of the shares of the stock are sold short. Based on an average daily volume of 300 shares, the days-to-cover ratio is currently 3,578.0 days.

Recordati Industria Chimica e Farmaceutica Stock Performance

Shares of Recordati Industria Chimica e Farmaceutica stock remained flat at $56.04 during trading on Thursday. The company has a 50 day moving average price of $53.98 and a two-hundred day moving average price of $53.85. The stock has a market capitalization of $11.56 billion, a price-to-earnings ratio of 28.02 and a beta of 0.26. Recordati Industria Chimica e Farmaceutica has a fifty-two week low of $49.00 and a fifty-two week high of $56.04.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.